Intrastromal Delivery of Bevacizumab Using Microneedles to Treat Corneal Neovascularization
Open Access
- 1 November 2014
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 55 (11), 7376-7386
- https://doi.org/10.1167/iovs.14-15257
Abstract
Purpose.: This study tested the hypothesis that highly targeted intrastromal delivery of bevacizumab using coated microneedles allows dramatic dose sparing compared with subconjunctival and topical delivery for treatment of corneal neovascularization. Methods.: Stainless steel microneedles 400 μm in length were coated with bevacizumab. A silk suture was placed in the cornea approximately 1 mm from the limbus to induce corneal neovascularization in the eyes of New Zealand white rabbits that were divided into different groups: untreated, microneedle delivery, topical eye drop, and subconjunctival injection of bevacizumab. All drug treatments were initiated 4 days after suture placement and area of neovascularization was measured daily by digital photography for 18 days. Results.: Eyes treated once with 4.4 μg bevacizumab using microneedles reduced neovascularization compared with untreated eyes by 44% (day 18). Eyes treated once with 2500 μg bevacizumab using subconjunctival injection gave similar results to microneedle-treated eyes. Eyes treated once with 4.4 μg subconjunctival bevacizumab showed no significant effect compared with untreated eyes. Eyes treated with 52,500 μg bevacizumab by eye drops three times per day for 14 days reduced the neovascularization area compared with untreated eyes by 6% (day 18), which was significantly less effective than the single microneedle treatment. Visual exam and histological analysis showed no observable effect of microneedle treatment on corneal transparency or microanatomical structure. Conclusions.: This study shows that microneedles can target drug delivery to corneal stroma in a minimally invasive way and demonstrates effective suppression of corneal neovascularization after suture-induced injury using a much lower dose compared with conventional methods.Keywords
This publication has 46 references indexed in Scilit:
- Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the EyeInvestigative Opthalmology & Visual Science, 2012
- Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse ModelPLOS ONE, 2010
- Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow MicroneedlesPharmaceutical Research, 2010
- Dissolving polymer microneedle patches for influenza vaccinationNature Medicine, 2010
- Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant SurvivalInvestigative Opthalmology & Visual Science, 2010
- Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safetyDrug Delivery, 2010
- Intrascleral Drug Delivery to the Eye Using Hollow MicroneedlesPharmaceutical Research, 2008
- Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1Prostaglandins & Other Lipid Mediators, 2007
- Mechanisms of adverse effects of anti-VEGF therapy for cancerBritish Journal of Cancer, 2007
- Coated microneedles for transdermal deliveryJournal of Controlled Release, 2006